MOLOGEN applies for clinical study with cell-based gene therapy for renal cancer - PipelineReview.com (press release) PDF Print
PipelineReview.com (press release)MGN1601 is a cell-based gene therapy for the treatment of advanced renal cancer. The purpose of this phase I/II clinical study (ASET study) is to

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.